US Stock MarketDetailed Quotes

MACK Merrimack Pharmaceuticals

Watchlist
  • 15.130
  • 0.0000.00%
Close May 17 16:00 ET
223.75MMarket Cap1.09P/E (TTM)

About Merrimack Pharmaceuticals Company

Merrimack Pharmaceuticals Inc is a biotechnology company that discovers, develops, and commercializes innovative medicines that consist of novel therapeutics paired with diagnostics to treat cancer. The company's core approach to systems biology is to apply multidisciplinary capabilities to build functional and predictive computational models of biological systems, such as cell signaling networks. Merrimack also enters into third-party agreements to further process and commercialize its products.

Company Profile

SymbolMACK
Company NameMerrimack Pharmaceuticals
Issue Price7.00
CEOMr. Gary L. Crocker
MarketNASDAQ
Fiscal Year Ends12-31

Company Executives

  • Name
  • Position
  • Salary
  • Gary L. Crocker
  • Chairman of the Board, President, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer
  • --
  • Eric D. Andersen
  • Independent Director
  • --
  • Dr. Ulrik B. Nielsen
  • Independent Director
  • --
  • Noah G. Levy
  • Independent Director
  • --
  • Ana Radeljevic
  • Independent Director
  • --
Trending Stocks
Donald Trump Donald Trump

Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump. Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump.